InsiderTrades.com logo
Forget NVIDIA, buy this $2 AI stock now…
From Behind the Markets   |   Ad
This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.
Click here to learn more >>>

AC8 Insider Trading

Insider Ownership Percentage: 27.87%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

AusCann Group Insider Trading History Chart

This chart shows the insider buying and selling history at AusCann Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AusCann Group Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/12/2020 01:00 AM ET

This chart shows the closing price history over time for AC8 up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Your Money is Not Safe
From American Alternative   |   Ad
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
CLICK HERE TO GET YOUR GUIDE NOW

AusCann Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/14/2021Geoff StarrInsiderBuy100,000A$0.12A$11,500.00
4/15/2021Robert (Max) JohnstonInsiderBuy110,000A$0.14A$15,400.00
See Full Table
Your Money is Not Safe
From American Alternative   |   Ad
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
CLICK HERE TO GET YOUR GUIDE NOW

SEC Filings (Institutional Ownership Changes) for AusCann Group (ASX:AC8)

16.43% of AusCann Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. AusCann Group Holdings Ltd is based in West Perth, Australia.
Read More on AusCann Group

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

537,446 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

6.79%

Beta

0.73
Forget NVIDIA, buy this $2 AI stock now…
From Behind the Markets   |   Ad
This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.
Click here to learn more >>>